- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
research use only
Cat.No.S8369
| Related Targets | CXCR Nrf2 Mitophagy LRRK2 ULK FKBP Heme Oxygenase LC3 cGAS Cell wall |
|---|---|
| Other Autophagy Products | Resveratrol (trans-Resveratrol) Spautin-1 PIK-III DC661 Autophinib SMER28 EAD1 Flubendazole EN6 ROC-325 |
|
In vitro |
DMSO
: 9 mg/mL
(16.37 mM)
Water : 3 mg/mL Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 549.75 | Formula | C23H23Cl2N5.3HCl |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1391426-24-6 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CN(CCNC1=C2C=CC(=CC2=NC=C1)Cl)CCNC3=C4C=CC(=CC4=NC=C3)Cl.Cl.Cl.Cl | ||
| Targets/IC50/Ki |
Autophagy
|
|---|---|
| In vitro |
Lys05 is water soluble salt of Lys01. This compound shows potent antitumor activity as a single agent both in vitro and in vivo in multiple human cancer cell lines and xenograft models. Lys01 and this chemical produce equivalent dose-dependent increases in the LC3II/LC3I ratio, accumulation of the autophagy cargo protein p62, and identical IC50 values in the MTT assay. |
| In vivo |
While lower doses of Lys05 are well tolerated and associated with antitumor activity, at the highest dose tested, this compound produces Paneth cell dysfunction and intestinal toxicity, similar to what can be observed in mice and humans with genetic defects in the autophagy gene ATG16L1. In two melanoma xenograft models and a colon cancer xenograft model, intermittent high dose or chronic daily dosing of this chemical at lower doses produces significant early blockade of autophagy in vivo, and has single-agent antitumor activity at doses as low as 10 mg/kg i.p. daily. |
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.